Evidence map›Paper›PMID 27831799›Full record

ArticleAnnals of the American Thoracic Society2016

Treatment of Drug-Susceptible Tuberculosis.

Charles S Dela Cruz, Patrick G Lyons, Susan Pasnick, Tanya Weinstock, Payam Nahid, Kevin C Wilson, Carey C Thomson

Abstract readComment
PubMed Publisher
In one paragraph

Article in Annals of the American Thoracic Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Novel Isoniazid-Carborane Hybrids Active in Vitro AgainstPharmaceuticals (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Charles S Dela Cruz1 Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
Patrick G Lyons2 Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Susan Pasnick3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
Tanya Weinstock4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.
Payam Nahid3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
Kevin C Wilson6 Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Boston University Medical Center, Boston, Massachusetts.
Carey C Thomson4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsTuberculosisDrug Resistance, BacterialHumansMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular Agents

Identifiers

PMID27831799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.